GAPP2™: One in Four Type 2 Diabetes Patients in Canada using Insulin Analogues had Irregularities in their Basal Insulin Dosing in the Preceding 30 Days.

✍ Scribed by Woo, Vincent C.; Brod, Meryl; Barnett, Anthony H.; Peyrot, Mark; Leiter, Lawrence A.

• Book ID: 123370383
• Publisher: Canadian Diabetes Association
• Year: 2012
• Tongue: English
• Weight: 56 KB
• Volume: 36
• Category: Article
• ISSN: 1499-2671
• DOI: 10.1016/j.jcjd.2012.07.343